Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0baed4e3a9c5c16cf3ec12d41f84d920 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1305 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-999 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-1384 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-38 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3804 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0653 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0655 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3852 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-077 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02 |
filingDate |
2004-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ade7a9e93fd1cc1f99f3fce4fe1bf0e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f2bbe8fe8e86daa878bd951e709079d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cbee41e81bf3b316c382af07b1e7040 |
publicationDate |
2005-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2005112761-A1 |
titleOfInvention |
Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair |
abstract |
Methods and compositions for directing adipose-derived stromal cells cultivated in vitro to differentiate into cells of the chondrocyte lineage are disclosed. The invention further provides a variety of chondroinductive agents which can be used singly or in combination with other nutrient components to induce chondrogenesis in adipose-derived stromal cells either in cultivating monolayers or in a biocompatible lattice or matrix in a three-dimensional configuration. Use of the differentiated chondrocytes for the therapeutic treatment of a number of human conditions and diseases including repair of cartilage in vivo is disclosed. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006134781-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8221500-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8883210-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9352003-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10531957-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11305035-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8435551-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8906110-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11555172-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7815926-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7837740-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE42208-E http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8292968-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE43258-E http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005251268-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9701940-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11596517-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7901457-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10130736-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8834928-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10077420-B2 |
priorityDate |
1999-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |